2016 American Transplant Congress
Pancreas Retransplantation – Is It Worth It?
Background: Pancreas transplantation is well established therapy for insulin-dependent diabetic patients. Management of patients with failed graft by retransplantation might be associated with increased technical…2016 American Transplant Congress
Impact of Early Acute Rejection (AR) on Pancreas Transplant (PT) Outcomes.
University of Minnesota, Minneapolis.
Background: The role of early AR in long-term PT outcomes remains unclear. Despite reported high rate of AR (up to 40% in PTA), graft survival…2016 American Transplant Congress
Virtual Crossmatch in Simultaneous Pancreas-Kidney Transplant.
Background: Simultaneous pancreas-kidney transplant (SPKT) outcomes have improved over the years. Methods: Analyses of demographic data of patients submitted to SPKT from Dec/2000 to Sep/2015…2016 American Transplant Congress
Antibody-Mediated Rejection in Pancreas Transplantation.
PURPOSE: The diagnostic criteria for antibody-mediated rejection (AMR) in pancreas transplantation (PTx) is evolving. The incidence and long-term effect of AMR have not been well-described.…2016 American Transplant Congress
The Impact of Different Immunosuppressive Protocols on Early and Long Term Outcomes After Kidney and Pancreas Transplantation.
Surgery/Transplant, The Ohio State University Wexner Medical Center, Columbus, OH.
Between January 1990 and December 2014, 800 combined kidney pancreas transplant procedures were performed at The Ohio State University. The immunosuppressive protocols have changed significantly…2016 American Transplant Congress
Conversion from Tacrolimus to Belatacept in Pancreas Transplant Alone Recipients with Chronic Kidney Disease.
Medicine/Nephrology & Surgery/Transplant, Indiana University, Indianapolis.
Background: CNI toxicity is a well known risk factor for chronic kidney disease and ESRD in organ transplants. We report our experience in converting Pancreas…2016 American Transplant Congress
Outcomes with Steroids Alone for Biopsy-Proven Pancreas Transplant Rejection.
There is little published data on the response of pancreas rejection to steroids alone. We reviewed 42 pancreas transplant recipients between 01/1997 and 12/2013 at…2016 American Transplant Congress
Incidence and Indications for Pancreatectomy After Late Pancreas Allograft Failure.
University of Wisconsin School of Medicine and Public Health, Madison, WI.
There is little information about incidence, indications and risk factors for late allograft pancreatectomy (PTX) in patients with ongoing immunosuppression for a functional kidney allograft.We…2016 American Transplant Congress
Graft Versus Host Disease (GVHD) in Patients with Pancreas Transplant Alone (PTA).
GVHD is rare after kidney-pancreas transplant with 18 case reports to date and never been described in the setting of PTA.We share our experience.Patient A:…2016 American Transplant Congress
Pancreas After Islet Transplantation – A Successful Treatment Option After a Failed Islet Transplant.
Department of Surgery, SUNY Upstate Medical University, Syracuse, NY.
Introduction: Pancreas after islet (PAI) transplantation (tx) is a treatment option for patients seeking insulin independence through a whole organ transplant after a previous, failed…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 28
- Next Page »